# Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

> **NCT00031889** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 5 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Exemestane
- **DRUG:** Exemestane+bicalutamide

## Key facts

- **NCT ID:** NCT00031889
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031889, "Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00031889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*